Global Radiotherapy Market - Growth, Trends & Forecasts (2017 - 2022)

The Global Radiotherapy Market has been estimated at USD XX billion in 2015 and is projected to reach USD XX billion by 2020, at a CAGR of XX% during the forecast period from 2015 to 2021. Radiation therapy uses high energy radiation on targeted cells and cell growth to stop them from growing and dividing. It is a local treatment like surgery and affects a specific area only.

Radiation can come from a machine (external radiation), from implants (internal radiation) placed near the tumors. Radiotherapy is mostly and widely used for the treatment of cancerous tumor, benign tumors and other conditions like thyroid disease and some blood disorders.

The global radiotherapy market is driven by a number of factors like an increase in the number of cancer patients, reduction in the cost of treatment in many developed countries, huge government and non government investments in Research and Development of cancer treatment and preference for non invasive procedures of treatment. However, the lack of skilled personnel to perform the therapy, competent alternative therapy, its inability to be used for metastasis state of cancer and side effects like skin rashes, scar tissue formation have restrained the market growth.

The radiotherapy market is segmented based on the types of radiotherapy, application and by the equipments used. Based on the type of radiotherapy, the market is further segmented as external beam radiation therapy, internal radiation therapy and systemic radiation therapy. The external beam radiation therapy is further sub segmented as intensity modulated radiation therapy, image guided radiation therapy, tomotherapy, stereotactic radio surgery, stereotactic body radiation therapy and proton therapy. Based on application the market is segmented as skin and lip cancer, head and neck cancer, breast cancer, prostate cancer, cervical cancer, lung cancer, spine cancer and others like thyroid treatment. Based on equipment used, the radiotherapy market is segmented as linear accelerators, radiation therapy simulators and treatment planning systems.

Based on geographical location, the radiotherapy market can be divided into North America (USA, Canada and Mexico), Europe (France, UK, Germany, Spain, Portugal, Russia and Italy), Asia-Pacific (India, China, Japan, South Korea, Australia, New Zealand), Middle East and Africa (GCC, Egypt) and Latin America (Brazil and Argentina).

The increasing technological innovations and rise in healthcare expenditure and global GDP are some of the market opportunities for the key market vendors. However, they face the challenges to deal with cost of equipment and therapy especially in developing countries and stringent regulations and reimbursement policies. The key market players in the industry are GE Healthcare, Siemens, IBA, Varian, Cardinal Health, Nordion, Isoray among many others.

Key Deliverables

Market analysis for the global radiotherapy market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
Extensively researched competitive landscape section with profiles of major companies along with their market shares
Identification and analysis of the macro and micro factors that affect the Global radiotherapy Market
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped


1.1 Study deliveratives

1.2 Market Definition

1.3 Sizing Units

1.4 Base Currency

1.5 Review and forecasr period years

1.6 General Study Assumptions


2.1 Introduction

2.2 Analysis Methodology

2.3 Econometric forecast models

2.4 Research Assumptions




5.1 Current market scenario

5.2 Technology Overview

5.3 New developments in therapeutics

5.4 Investment analysis

5.5 Porters Five Force Analysis

5.5.1 Bargaining Power of suppliers

5.5.2 Bargaining power of buyers

5.5.3 Degree of competition

5.5.4 Threat of substitution

5.5.5 Threat of new entrants


6.1 Market Drivers

6.1.1 Increase in the number of cancer patients

6.1.2 Reduction in the cost of treatment

6.1.3 Lucrative reimbursement plans

6.1.4 Huge government & non-government investments in R&D of cancer treatment

6.1.5 Preference for non invasive procedure

6.2 Market Restraints

6.2.1 Lack of skilled personnel to perform radiotherapy

6.2.2 Competent alternative treatment

6.2.3 Not effective for metastasized state of cancer

6.2.4 Side effects like skin rashes, scar tissue formation and others are common

6.3 Market Opportunities

6.3.1 Technological innovations

6.3.2 Rise in healthcare expenditure and global GDP

6.4 Key Challenges

6.4.1 Cost of equipment and therapy

6.4.2 Stringent regulations and reimbursement policies

7. Global radiation therapy Segmentation

7.1 By types

7.1.1 External Beam Radiation Therapy Intensity-modulated radiation therapy (IMRT) Image-guided radiation therapy (IGRT) Tomotherapy Stereotactic radiosurgery Stereotactic body radiation therapy Proton therapy

7.1.2 Internal radiation therapy

7.1.3 Systemic radiation therapy

7.2 By application

7.2.1 Skin & Lip Cancer

7.2.2 Head & Neck Cancer

7.2.3 Breast Cancer

7.2.4 Prostate Cancer

7.2.5 Cervical Cancer

7.2.6 Lung Cancer

7.2.7 Spine Cancer

7.2.8 Others

7.3 By equipment

7.3.1 Linear Accelerators

7.3.2 Radiation Therapy Simulators

7.3.3 Treatment Planning Systems

8. Global radiotherapy by Georaphy - Regional shares and forecast

8.1 North America

8.1.1 Introduction

8.1.2 USA

8.1.3 Canada

8.1.4 Mexico

8.1.5 Rest of North America

8.2 Europe

8.2.1 Introduction

8.2.2 France

8.2.3 UK

8.2.4 Germany

8.2.5 Spain and Portugal

8.2.6 Russia

8.2.7 Italy

8.2.8 Rest of Europe

8.3 Asia-Pacific

8.3.1 Introduction

8.3.2 India

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 Australia and New Zealand

8.3.7 Rest of Asia Pacific

8.4 Middle East and Africa

8.4.1 Introduction

8.4.2 GCC

8.4.3 Egypt

8.4.4 Rest of Middle East and Africa

8.5 Latin America

8.5.1 Introduction

8.5.2 Brazil

8.5.3 Argentina

8.5.4 Rest of Latin America



10.1 GE Healthcare

10.2 Siemens

10.3 Toshiba

10.4 IBA

10.5 Varian

10.6 Cardinal Health

10.7 Nordion

10.8 Isoray

10.9 Radcalc

10.10 Mirada Medical

11. Analyst outlook for Investment Opportunities

12. Future outlook of the market


13.1 Abbrevations

13.2 Bibliography

13.3 Disclaimer

Content are not available

Choose License Type